Aardvark Therapeutics, Inc. (NASDAQ:AARD) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Roy Baynes Other companies: Eikon Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 4, 2026); Nurix Therapeutics, Inc. (Director · Since at least Mar 11, 2025); Natera, Inc. (Director · Since at least Jul 25, 2018); Travere Therapeutics, Inc. (Director · Since at least Jul 19, 2016); Atara Biotherapeutics, Inc. (Director · Sep 11, 2018 – Jun 23, 2022 · Past) | Director · Since at least Feb 12, 2025 |
| Susan E. Graf Other companies: CG Oncology, Inc. (Director · Since at least Jan 24, 2024); Epizyme Inc (Chief Business Officer · Apr 25, 2016 – Feb 9, 2018 · Past) | Board Member · Since at least Feb 12, 2025 |
| Jeffrey Chi Other companies: Scilex Holding Company (Director · Jan 6, 2021 – Jan 6, 2021 · Past) | Vice Chairman · Since at least Feb 12, 2025 |
| Tien Lee Other companies: Scilex Holding Company (Director · Nov 10, 2022 – Jan 17, 2023 · Past) | Chief Executive Officer · Since at least Feb 12, 2025 |
| Victor Edward Tong Jr Other companies: CG Oncology, Inc. (Director · Since at least Jan 24, 2024) | Director · Since at least Feb 12, 2025 |
| Victor Tong Other companies: CG Oncology, Inc. (Managing Director, Decheng Capital · Since at least Nov 5, 2026) | Managing Director · Since at least Nov 5, 2026 |
| Bryan Jones | Chief Operating Officer · Since at least Feb 12, 2025 |
| Christopher J. Kemmerer | EVP, Technical Operations · Since at least Nov 4, 2026 |
| David Zhang | Chief Strategy Officer · Since at least Oct 8, 2026 |
| Derrick Li | Chief Business Officer · Since at least Feb 12, 2026 |
| Dvorit Samid | EVP, Medical Affairs · Since at least Nov 4, 2026 |
| Justin Stege | VP, Head of Project Management and Strategy · Since at least Nov 4, 2026 |
| Manasi Jaiman | Chief Medical Officer · Since at least Feb 12, 2025 |
| Nelson Sun | Chief Operating Officer & Chief Financial Officer · Since at least Feb 12, 2025 |
| Ron Lewis | VP, Head of CMC · Since at least Nov 4, 2026 |
| Zhenhuan Zheng | Chief Research Officer · Since at least Nov 4, 2026 |